1,808
Views
61
CrossRef citations to date
0
Altmetric
Research Paper

Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis

, , , , , , , , & ORCID Icon show all
Pages 1479-1488 | Received 06 Jun 2014, Accepted 28 Jul 2014, Published online: 16 Dec 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Qingrong Li, Qiang Ma, Jibing Cheng, Xi Zhou, Wenjie Pu, Xiaowu Zhong & Xiaolan Guo. (2021) Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies. OncoTargets and Therapy 14, pages 2563-2573.
Read now
Xuanxuan Liu, Xingxing Wang, Yan Pan, Li Zhao, Shuo Sun, Ang Luo, Changlei Bao, Haiyang Tang & Ying Han. (2021) Artemisinin Improves Acetylcholine-Induced Vasodilatation in Rats with Primary Hypertension. Drug Design, Development and Therapy 15, pages 4489-4502.
Read now
Dongning Li, Jie Zhang & Xiaoyan Zhao. (2021) Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment. Cancer Investigation 39:8, pages 675-684.
Read now
Afsaneh Sadremomtaz, Farzad Kobarfard, Kamran Mansouri, Laleh Mirzanejad & S. Mohsen Asghari. (2018) Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2. Journal of Receptors and Signal Transduction 38:5-6, pages 432-441.
Read now

Articles from other publishers (56)

Surya Kant Tripathi, Stuti Biswal, Munmun Panda & Bijesh Kumar Biswal. 2023. Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach. Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach 210 248 .
Die Jiang, Ting Xu, Lei Zhong, Qi Liang, Yonghe Hu, Wenjing Xiao & Jianyou Shi. (2023) Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases. European Journal of Medicinal Chemistry 257, pages 115535.
Crossref
Olagoke Zacchaeus Olatunde, Jianping Yong & Canzhong Lu. (2023) An Overview of Dihydroartemisinin as a Promising Lead Compound for Development of Anticancer Agents. Mini-Reviews in Medicinal Chemistry 23:3, pages 265-289.
Crossref
Yijing Jiang, Jie Zhang, Conglin Shi, Xingjuan Li, Yongying Jiang & Renfang Mao. (2023) NF- κ B: a mediator that promotes or inhibits angiogenesis in human diseases? . Expert Reviews in Molecular Medicine 25.
Crossref
Lei Zhao, Ranakul Islam, Yifang Wang, Xiujuan Zhang & Ling-Zhi Liu. (2022) Epigenetic Regulation in Chromium-, Nickel- and Cadmium-Induced Carcinogenesis. Cancers 14:23, pages 5768.
Crossref
Lingfeng Shi, Yixiang Li, Xiaoli Xu, Yangyang Cheng, Biying Meng, Jinling Xu, Lin Xiang, Jiajia Zhang, Kaiyue He, Jiayue Tong, Junxia Zhang, Lingwei Xiang & Guangda Xiang. (2022) Brown adipose tissue-derived Nrg4 alleviates endothelial inflammation and atherosclerosis in male mice. Nature Metabolism 4:11, pages 1573-1590.
Crossref
Shipra Singhal, Priyal Maheshwari, Praveen Thaggikuppe Krishnamurthy & Vaishali M. Patil. (2022) Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics. Anti-Cancer Agents in Medicinal Chemistry 22:15, pages 2726-2756.
Crossref
Fuhong Liu, Jing Liu, Hongjie Xiang, Zongguo Sun, Yan Li, Xiao Li, Yanjun Liu & Ju Liu. (2022) Dihydroartemisinin protects blood–brain barrier permeability during sepsis by inhibiting the transcription factor SNAI1 . Clinical and Experimental Pharmacology and Physiology 49:9, pages 979-987.
Crossref
Jibo Li, Yongsong Bai, Kaidi Ma, Zhongshuai Ren, Jianping Li, Jing Zhang & Anshan Shan. (2022) Dihydroartemisinin alleviates deoxynivalenol induced liver apoptosis and inflammation in piglets. Ecotoxicology and Environmental Safety 241, pages 113811.
Crossref
Jianbo Zhou, Li Wang, Cheng Peng & Fu Peng. (2022) Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology. Frontiers in Pharmacology 13.
Crossref
Yan Zhou, Jun-hao Wang, Jian-peng Han, Jian-yong Feng, Kuo Guo, Fei Du, Wen-bin Chen & Yong-zhang Li. (2022) Dihydroartemisinin ameliorates chronic nonbacterial prostatitis and epithelial cellular inflammation by blocking the E2F7/HIF1α pathway. Inflammation Research 71:4, pages 449-460.
Crossref
Xun Li, Sheng Gao, Yun Zhang, Mei Xin, Cheng Zuo, Naihong Yan, Qingjie Xia & Meixia Zhang. (2022) Dihydroartemisinin Inhibits Laser-Induced Choroidal Neovascularization in a Mouse Model of Neovascular AMD. Frontiers in Pharmacology 13.
Crossref
Karim Farmanpour-Kalalagh, Arman Beyraghdar Kashkooli, Alireza Babaei, Ali Rezaei & Alexander R. van der Krol. (2022) Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand. Frontiers in Plant Science 13.
Crossref
Yan-Bing Huo, Xiang Gao, Qi Peng, Qiang Nie & Wei Bi. (2022) Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO/NR4A3 axis. Inflammation Research 71:2, pages 243-253.
Crossref
Yuanyuan Liu, Yingying Tian, Yao Guo, Ziyi Yan, Changhu Xue & Jingfeng Wang. (2021) DHA-enriched phosphatidylcholine suppressed angiogenesis by activating PPARγ and modulating the VEGFR2/Ras/ERK pathway in human umbilical vein endothelial cells. Food Science and Biotechnology 30:12, pages 1543-1553.
Crossref
Qingrong Li, Qiang Ma, Lei Xu, Chuanli Gao, Lihua Yao, Jilin Wen, Miyuan Yang, Jibing Cheng, Xi Zhou, Jiang Zou, Xiaowu Zhong & Xiaolan Guo. (2021) Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer. Frontiers in Pharmacology 12.
Crossref
Jianqing Peng, Qin Wang, Jia Zhou, Shuli Zhao, Pan Di, Yan Chen, Ling Tao, Qianming Du, Xiangchun Shen & Yi Chen. (2021) Targeted Lipid Nanoparticles Encapsulating Dihydroartemisinin and Chloroquine Phosphate for Suppressing the Proliferation and Liver Metastasis of Colorectal Cancer. Frontiers in Pharmacology 12.
Crossref
Joana F. S. Pereira, Peter Jordan & Paulo Matos. (2021) A Signaling View into the Inflammatory Tumor Microenvironment. Immuno 1:2, pages 91-118.
Crossref
Yanping Hu, Yujin Wang, Na Li, Li Chen & Jianbo Sun. (2021) Discovery of novel dihydroartemisinin-cinnamic hybrids inducing lung cancer cells apoptosis via inhibition of Akt/Bad signal pathway. Bioorganic Chemistry 111, pages 104903.
Crossref
Amit Joharapurkar, Vishal Patel, Samadhan Kshirsagar, Maulik S. Patel, Hardikkumar Savsani & Mukul Jain. (2021) Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy. European Journal of Pharmacology 899, pages 174032.
Crossref
Fengyun Dong, Xinghai Zhao, Jianning Wang, Xin Huang, Xiao Li, Liang Zhang, Haixin Dong, Fuhong Liu & Mengge Fan. (2020) Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cells. Fundamental & Clinical Pharmacology 35:2, pages 321-330.
Crossref
Qiong Luo, Suyun Zhang, Donghuan Zhang, Rui Feng, Nan Li, Wujin Chen, Xiangqi Chen & Sheng Yang. (2021) Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells. Current Pharmaceutical Biotechnology 22:4, pages 523-533.
Crossref
Dariya Begum, Neha Merchant & Ganji Purnachandra Nagaraju. 2021. A Theranostic and Precision Medicine Approach for Female-Specific Cancers. A Theranostic and Precision Medicine Approach for Female-Specific Cancers 1 30 .
Ya-yi Jiang, Jia-cheng Shui, Bo-xun Zhang, Jia-wei Chin & Ren-song Yue. (2020) The Potential Roles of Artemisinin and Its Derivatives in the Treatment of Type 2 Diabetes Mellitus. Frontiers in Pharmacology 11.
Crossref
Ran Yu, Linbo Jin, Fangfang Li, Manabu Fujimoto, Qiang Wei, Zhenhua Lin, Xiangshan Ren, Quanxin Jin, Honghua Li, Fanping Meng & Guihua Jin. (2020) Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner. Journal of Dermatological Science 99:3, pages 193-202.
Crossref
Bingqi Yang, Xueliang Gao, Yunchao Sun, Jianing Zhao, Jie Chen, Limin Gao, Li Zhao & Yongzhang Li. (2020) Dihydroartemisinin alleviates high glucose-induced vascular smooth muscle cells proliferation and inflammation by depressing the miR-376b-3p/KLF15 pathway. Biochemical and Biophysical Research Communications 530:3, pages 574-580.
Crossref
Bushra Hafeez Kiani, Waqas Khan Kayani, Asma Umer Khayam, Erum Dilshad, Hammad Ismail & Bushra Mirza. (2020) Artemisinin and its derivatives: a promising cancer therapy. Molecular Biology Reports 47:8, pages 6321-6336.
Crossref
Maria Grazia Rossino, Matteo Lulli, Rosario Amato, Maurizio Cammalleri, Massimo Dal Monte & Giovanni Casini. (2020) Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy. Cells 9:6, pages 1452.
Crossref
Yue Li, Xiaoyan Zhou, Jiali Liu, Xiaohong Yuan & Qian He. (2020) Therapeutic Potentials and Mechanisms of Artemisinin and its Derivatives for Tumorigenesis and Metastasis. Anti-Cancer Agents in Medicinal Chemistry 20:5, pages 520-535.
Crossref
Peng Gao, Li-li Wang, Jing Liu, Fengyun Dong, Wei Song, Lin Liao, Bei Wang, Wenqian Zhang, Xia Zhou, Qi Xie, Rong Sun & Ju Liu. (2020) Dihydroartemisinin inhibits endothelial cell tube formation by suppression of the STAT3 signaling pathway. Life Sciences 242, pages 117221.
Crossref
Hua Luo, Chi Teng Vong, Hanbin Chen, Yan Gao, Peng Lyu, Ling Qiu, Mingming Zhao, Qiao Liu, Zehua Cheng, Jian Zou, Peifen Yao, Caifang Gao, Jinchao Wei, Carolina Oi Lam Ung, Shengpeng Wang, Zhangfeng Zhong & Yitao Wang. (2019) Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chinese Medicine 14:1.
Crossref
Ning Li, Wenjing Sun, Xin Zhou, Hao Gong, Yuqing Chen, Dongfeng Chen & Fei Xiang. (2019) Dihydroartemisinin Protects against Dextran Sulfate Sodium-Induced Colitis in Mice through Inhibiting the PI3K/AKT and NF- κ B Signaling Pathways . BioMed Research International 2019, pages 1-12.
Crossref
Juan Yang, Haining Li, Zhao Wang, Liming Yu, Qiang Liu, Xiaoyan Niu, Ting Xu & Zhenhai Wang. (2019) Dihydroartemisinin inhibits multiplication of Brucella suis vaccine strain 2 in murine microglia BV2 cells via stimulation of caspase‑dependent apoptosis. Molecular Medicine Reports.
Crossref
Nan Li, Suyun Zhang, Qiong Luo, Fang Yuan, Rui Feng, Xiangqi Chen & Sheng Yang. (2019) The Effect of Dihydroartemisinin on the Malignancy and Epithelial-Mesenchymal Transition of Gastric Cancer Cells. Current Pharmaceutical Biotechnology 20:9, pages 719-726.
Crossref
Rui-Jie Ma, Ming-Jing He, Ya-Qin Tan & Gang Zhou. (2019) Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus. Inflammation Research 68:4, pages 297-310.
Crossref
Rui Yan, Matijs van Meurs, Eliane R. Popa, Ranran Li, Peter J. Zwiers, Jan G. Zijlstra, Jill Moser & Grietje Molema. (2019) Early Heterogenic Response of Renal Microvasculature to Hemorrhagic Shock/Resuscitation and the Influence of NF-κB Pathway Blockade. Shock 51:2, pages 200-212.
Crossref
Jie Yin, Weiwei Xia, Yue Zhang, Guixia Ding, Lihong Chen, Guangrui Yang, Songming Huang, Zhanjun Jia & Aihua Zhang. (2018) Role of dihydroartemisinin in regulating prostaglandin E2 synthesis cascade and inflammation in endothelial cells. Heart and Vessels 33:11, pages 1411-1422.
Crossref
Congran Zhou, Xinwei Tang, Jingkui Xu, Jiajia Wang, Yaping Yang, Yehui Chen, Lixin Chen, Liwei Wang, Linyan Zhu & Haifeng Yang. (2018) Opening of the CLC‐3 chloride channel induced by dihydroartemisinin contributed to early apoptotic events in human poorly differentiated nasopharyngeal carcinoma cells. Journal of Cellular Biochemistry 119:11, pages 9560-9572.
Crossref
D. Jian, W. Wang, X. Zhou, Z. Jia, J. Wang, M. Yang, W. Zhao, Z. Jiang, X. Hu & J. Zhu. (2018) Interferon-induced protein 35 inhibits endothelial cell proliferation, migration and re-endothelialization of injured arteries by inhibiting the nuclear factor-kappa B pathway. Acta Physiologica 223:3, pages e13037.
Crossref
Zuowang Cheng, Ruixia Qi, Liqun Li, Qiang Liu, Wenqian Zhang, Xia Zhou, Dongmei Xu, Thaddeus D. Allen, Silin Pan & Ju Liu. (2018) Dihydroartemisinin ameliorates sepsis-induced hyperpermeability of glomerular endothelium via up-regulation of occludin expression. Biomedicine & Pharmacotherapy 99, pages 313-318.
Crossref
Dina VaraJoanna M. WattTiago M. FortunatoHarry MellorMatthew BurgessKate WicksKimberly MaceShaun ReekstingAnneke LubbenCaroline P.D. Wheeler-JonesGiordano Pula. (2018) Direct Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis. Antioxidants & Redox Signaling 28:2, pages 110-130.
Crossref
Yao Yu, Xue-Zhi Zhou, Lei Ye, Qing Yuan, Shelby Freeberg, Ce Shi, Pei-Wen Zhu, Jing Bao, Nan Jiang & Yi Shao. (2018) Rhamnazin attenuates inflammation and inhibits alkali burn-induced corneal neovascularization in rats. RSC Advances 8:47, pages 26696-26706.
Crossref
Tianshu Wei & Ju Liu. (2017) Anti-angiogenic properties of artemisinin derivatives (Review). International Journal of Molecular Medicine 40:4, pages 972-978.
Crossref
Thomas Efferth. (2017) From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy. Seminars in Cancer Biology 46, pages 65-83.
Crossref
Chi Zhou, Qing-yun Zou, Hua Li, Rui-fang Wang, Ai-xia Liu, Ronald R Magness & Jing Zheng. (2017) Preeclampsia Downregulates MicroRNAs in Fetal Endothelial Cells: Roles of miR-29a/c-3p in Endothelial Function. The Journal of Clinical Endocrinology & Metabolism 102:9, pages 3470-3479.
Crossref
Tianshu Wei, Jin Jia, Youichiro Wada, Carolyn M. Kapron & Ju Liu. (2017) Dose dependent effects of cadmium on tumor angiogenesis. Oncotarget 8:27, pages 44944-44959.
Crossref
Yuhao Zhang & Krithika Lingappan. (2017) Differential sex-specific effects of oxygen toxicity in human umbilical vein endothelial cells. Biochemical and Biophysical Research Communications 486:2, pages 431-437.
Crossref
Fengyun Dong, Ju Han, Guoxian Jing, Xiaocui Chen, Suhua Yan, Longtao Yue, Zhiqun Cao, Xiaochun Liu, Guozhao Ma & Ju Liu. (2016) Dihydroartemisinin transiently activates the JNK/SAPK signaling pathway in endothelial cells. Oncology Letters 12:6, pages 4699-4704.
Crossref
Zhe Li, Qin Li, Jun Wu, Manyuan Wang & Junxian Yu. (2016) Artemisinin and Its Derivatives as a Repurposing Anticancer Agent: What Else Do We Need to Do?. Molecules 21:10, pages 1331.
Crossref
Kegang Linghu, Dan Lin, Hong Yang, Yini Xu, Yanyan Zhang, Ling Tao, Yan Chen & Xiangchun Shen. (2016) Ameliorating effects of 1,8-cineole on LPS-induced human umbilical vein endothelial cell injury by suppressing NF-κB signaling in vitro. European Journal of Pharmacology 789, pages 195-201.
Crossref
Jiao Zhang, Ling Guo, Xia Zhou, Fengyun Dong, Liqun Li, Zuowang Cheng, Yinghua Xu, Jiyong Liang, Qi Xie & Ju Liu. (2016) Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway. Oncology Letters 12:3, pages 1896-1900.
Crossref
Hongyan Zhang, Liqun Li, Yifan Wang, Fengyun Dong, Xiaocui Chen, Fuhong Liu, Dongmei Xu, Fan Yi, Carolyn M. Kapron & Ju Liu. (2016) NF-κB signaling maintains the survival of cadmium-exposed human renal glomerular endothelial cells. International Journal of Molecular Medicine 38:2, pages 417-422.
Crossref
Lin Zhou, Qian Liu, Mingli Yang, Tao Wang, Jun Yao, Jianwen Cheng, Jinbo Yuan, Xixi Lin, Jinmin Zhao, Jennifer Tickner & Jiake Xu. (2016) Dihydroartemisinin, an Anti-Malaria Drug, Suppresses Estrogen Deficiency-Induced Osteoporosis, Osteoclast Formation, and RANKL-Induced Signaling Pathways. Journal of Bone and Mineral Research 31:5, pages 964-974.
Crossref
Fuhong Liu, Bei Wang, Liqun Li, Fengyun Dong, Xiaocui Chen, Yan Li, Xiuzhen Dong, Youichiro Wada, Carolyn Kapron & Ju Liu. (2015) Low-Dose Cadmium Upregulates VEGF Expression in Lung Adenocarcinoma Cells. International Journal of Environmental Research and Public Health 12:9, pages 10508-10521.
Crossref
Fei Wu, Haibo Song, Yuan Zhang, Yuzhu Zhang, Qian Mu, Miao Jiang, Fang Wang, Wen Zhang, Liang Li, Huanjie Li, Yunshan Wang, Mingxiang Zhang, Shiwu Li, Lijun Yang, Yan Meng & Dongqi Tang. (2015) Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway. PLOS ONE 10:8, pages e0134662.
Crossref
Ju Liu, Yan Li, Fengyun Dong, Liqun Li, Takahiro Masuda, Thaddeus D. Allen & Corrinne G. Lobe. (2015) Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice. Biochemical and Biophysical Research Communications 463:4, pages 1230-1236.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.